Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Evercore HealthCONx Conference Transcript

Dec 04, 2019 / 04:45PM GMT
Release Date Price: €48.5 (+0.52%)
Luke England Sergott
Evercore ISI Institutional Equities, Research Division - Associate

All right. Okay. I guess we'll get started. I'm Luke Sergott. I cover the life sciences diagnostic tools here. I have the pleasure to be here with Chuck Kummeth of Bio-Techne. He's been there, 7 years you were just saying?

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Almost -- 7 in April.

Luke England Sergott
Evercore ISI Institutional Equities, Research Division - Associate

Almost 7 years running one of the best premier tools companies out there.

Questions & Answers

Luke England Sergott
Evercore ISI Institutional Equities, Research Division - Associate

So I guess, we can just kind of dive in. And I mean, as you look at the company today, and as you have been a consolidator, kind of walk us through the overall strategy. And if you look at some of those businesses that you have in the portfolio, some of them in more mature markets, some in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot